Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

Group B streptococcal conjugate vaccines.

Baker CJ, Edwards MS.

Arch Dis Child. 2003 May;88(5):375-8. Review.

2.

Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid.

Ahman H, Käyhty H, Vuorela A, Leroy O, Eskola J.

Vaccine. 1999 Jun 4;17(20-21):2726-32.

PMID:
10418924
3.

Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.

Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC.

Pediatrics. 2006 Apr;117(4):e717-24. Epub 2006 Mar 20.

PMID:
16549502
4.

Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults.

Baker CJ, Rench MA, Paoletti LC, Edwards MS.

Vaccine. 2007 Jan 2;25(1):55-63. Epub 2006 Jul 31.

PMID:
16919857
5.

Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.

Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Edwards MS, Kasper DL.

J Infect Dis. 2004 Mar 15;189(6):1103-12. Epub 2004 Mar 1.

6.

Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.

Palazzi DL, Rench MA, Edwards MS, Baker CJ.

J Infect Dis. 2004 Aug 1;190(3):558-64. Epub 2004 Jun 30.

7.

Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines.

Paoletti LC, Rench MA, Kasper DL, Molrine D, Ambrosino D, Baker CJ.

Infect Immun. 2001 Nov;69(11):6696-701. Erratum in: Infect Immun 2002 Jan;70(1):426.

8.

Haemophilus influenzae type b vaccines: history, choice and comparisons.

Decker MD, Edwards KM.

Pediatr Infect Dis J. 1998 Sep;17(9 Suppl):S113-6.

PMID:
9781742
9.
10.

Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.

Eskola J, Takala AK, Käyhty H.

Curr Opin Pediatr. 1993 Feb;5(1):55-9. Review.

PMID:
8374627
12.

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.

Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, Baker CJ.

J Clin Invest. 1996 Nov 15;98(10):2308-14.

13.

Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.

Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.

Vaccine. 2006 Mar 10;24(11):1776-85. Epub 2005 Oct 27.

PMID:
16303216
14.

Sustaining immunity after immunization against encapsulated bacteria.

Blanchard-Rohner G, Pollard AJ.

Hum Vaccin. 2008 Jul-Aug;4(4):309-12. Epub 2007 Dec 17.

PMID:
18398302
16.

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.

Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Carey VJ, Hickman ME, Kasper DL.

J Infect Dis. 2000 Oct;182(4):1129-38. Epub 2000 Sep 8.

17.

Glycoconjugate vaccines to prevent group B streptococcal infections.

Paoletti LC, Kasper DL.

Expert Opin Biol Ther. 2003 Sep;3(6):975-84. Review.

PMID:
12943456
18.
20.

[Conjugated vaccines].

Fritzell B.

Therapie. 2005 May-Jun;60(3):249-55. Review. French.

PMID:
16128267
Items per page

Supplemental Content

Write to the Help Desk